Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-01-02 @ 6:37 PM
Study NCT ID:
NCT04831658
Status:
UNKNOWN
Last Update Posted:
2022-06-02
First Post:
2021-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma
Sponsor:
Mingzhi Zhang
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-09-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-02
First Submit QC Date:
None
Study First Post Date:
2021-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-30
Last Update Post Date:
2022-06-02
Last Update Post Date Type:
ACTUAL